ERBB2 and breast cancer: Saleh et al. prepared HSA nanoparticles containing curcumin using a desolvation method and delivered them to HER-2 positive breast cancer cells in which the size of the nanoparticles was 246.1 ± 15.4 nm and the zeta potential value was −25 ± 2.7 mV [14].